Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-21-064884

Chief Financial Officer sold 150,000 shares at an average $12.31 ($1,846,567)

  • Chief Financial Officer acquired 150,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Murphy Amanda Louise · Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-12 Exercise or conversion : show line 1 in the form +51,103 $4.42 $225,875 51,103 D
2021-11-12 Sale : show line 2 in the form −51,103 $12.66 $646,964 0 D
2021-11-15 Exercise or conversion : show line 3 in the form +61,591 $4.42 $272,232 61,591 D
2021-11-15 Sale : show line 4 in the form −61,591 $12.16 $748,947 0 D
2021-11-16 Exercise or conversion : show line 5 in the form +37,306 $4.42 $164,893 37,306 D
2021-11-16 Sale : show line 6 in the form −37,306 $12.08 $450,656 0 D
Open-market sales · 150,000 sh · avg $12.31 · $1,846,567

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-11-12 Exercise or conversion : show line 7 in the form Employee Stock Option (right to buy) −51,103 1,098,897 D
2021-11-15 Exercise or conversion : show line 8 in the form Employee Stock Option (right to buy) −61,591 1,037,306 D
2021-11-16 Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) −37,306 1,000,000 D
Loading xslF345X03/doc4.xml…